Model Medicines, Inc.

New Filing
CIK: 0001892786·Biotechnology·DELAWARE·Filed: Feb 7, 2024
Total Offering

$2,000,000

Amount Sold

$950,000

Investors

10

First Sale

Dec 21, 2023

Offering Details

Type
Debt, Option to Acquire, Security to be Acquired, Other: Convertible Promissory Notes and Warrants
Exemptions
Rule 506(b)

Related Persons

NameRole
Daniel Haders
Executive Officer, Director
Marlon Evans
Executive Officer, Director
Kip Quackenbush
Executive Officer, Director

Company

Model Medicines, Inc.

1268 Prospect Street

La Jolla, CA, 92037

(858) 750-1298

SEC Filing

0001892786-24-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Model Medicines, Inc. Form D Filing — $2,000,000 | FilingFlow